Signify Premium Insight: ContextVision Weighs Digital Pathology Spin Off

In late August, image processing specialist ContextVision announced it was considering separating its digital pathology business from the rest of the company and is assessing listing the unit on the Euronext Growth index Oslo Stock Exchange. The split will leave the digital pathology business entirely distinct from the medical imaging division. The review of the split is expected to be completed by the end of Q42021, with the board of directors expecting the move to accelerate the growth of both parts of the business by allowing the management of each entity to focus on their own markets.